Aprecap Capsule

Aprecap Capsule

Aprecap Capsule contains aprepitant, an antiemetic medication used to prevent nausea and vomiting associated with chemotherapy and certain surgeries. It works by blocking the action of neurokinin-1 (NK1) receptors in the brain, which are responsible for triggering vomiting.

Key Features

• Contains aprepitant, a selective NK1 receptor antagonist.
• Effective for preventing both acute and delayed nausea/vomiting from chemotherapy.
• Can be used alongside other antiemetics for comprehensive prevention.

References

1. National Comprehensive Cancer Network (NCCN) Guidelines for Antiemesis
   Available from: https://www.ncbi.nlm.nih.gov/books/NBK551588
2. Aprepitant Product Information - FDA
   Available from: https://go.drugbank.com/drugs/DB00673

How it works

Aprepitant blocks neurokinin-1 (NK1) receptors, which play a key role in inducing nausea and vomiting. By inhibiting these receptors, Aprecap reduces the activity of chemicals in the brain that lead to these symptoms, particularly during chemotherapy.

• Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): Effective in both acute and delayed phases.
• Postoperative Nausea and Vomiting (PONV): Helps prevent nausea and vomiting following surgery.

• Fatigue
• Dizziness
• Hiccups
• Diarrhea
• Loss of appetite

Serious Side Effects (Seek Medical Attention)

• Allergic reactions (rash, itching, swelling of the face/tongue)
• Difficulty breathing
• Severe skin reactions (rare)